Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
This study is currently recruiting participants.
Verified September 2017 by Bayer
First Posted: September 23, 2013
Last Update Posted: September 11, 2017
Janssen Scientific Affairs, LLC
Information provided by (Responsible Party):